NCT07524231Recruiting
Evaluation of the Effects of Laughter Yoga
Evaluation of the Effects of Laughter Yoga on Pain Intensity, Stress, and Beta-endorphin Levels in Patients With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 11 Mar 2026
- Start date
- 10 Mar 2026
- Primary completion date
- 10 Jul 2026
- Lead sponsor
- Firat University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07524231
What you commit to
- Study type: Interventional
- Planned participants: 72
- From 10 Mar 2026 to the primary completion date, 10 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unwillingness to participate in the study
- Having severe cognitive impairment that prevents understanding or participation in the intervention
- Having a psychiatric disorder that may affect participation in the study
- Experiencing an acute MS relapse during the study period
- Having another serious neurological or chronic disease that may affect the study outcomes
- Regular participation in another complementary therapy program similar to laughter yoga
- Communication problems that prevent participation in the intervention sessions
Who the study is looking for
- • Being over 18 years old
- Being able to communicate adequately
- Volunteering to participate in the research
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gül DURAL Coordinator of this site? Confirm its status | Elâzığ | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.